StockData

ResMed vs Teleflex

RMD and TFX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RMD and TFX compare

ResMed is the larger company, worth 4.9 times as much as Teleflex ($33.5B against $6.8B).

Teleflex grew revenue faster over the last twelve months (30.7% versus 9.0% for ResMed).

ResMed keeps more of each dollar of sales as profit, with a net margin of 27.8% compared with −45.8% at Teleflex.

Both pay dividends: ResMed yields 0.78% and Teleflex 0.64%.

ResMed scores higher on the StockData Score (21 against 7 for Teleflex), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRMDTFX
Size and price
Market cap$33.5B$6.8B
Share price$237.85$159.55
Change, 1 year−2.7%49.1%
Change, 5 years−5.3%−47.7%
Beta (5Y)0.310.35
Employees11K16K
StockData Score
Total score21 (better)7
Valuation score4 (better)1
Growth score3 (better)1
Performance score6 (better)1
Health score4 (better)1
Dividend score4 (better)3
Valuation
P/E21.7×–
P/S5.8×3.0× (better)
P/B5.6×2.3× (better)
EV/EBITDA15.6× (better)48.1×
P/FCF20.8× (better)40.1×
PEG1.10–
FCF yield4.8% (better)2.5%
Fair value$276.76$37.56
Margin of safety14.1% (better)−325%
Growth
Revenue growth (TTM)9.0%30.7% (better)
Revenue growth, 5Y average12.1% (better)−4.7%
Net income growth (TTM)10.8% (better)−638%
EPS growth (TTM)12.4% (better)−645%
EPS growth, 5Y average26.3%–
Profitability
Gross margin61.1% (better)54.9%
Operating margin33.0% (better)2.0%
Net margin27.8% (better)−45.8%
FCF margin28.1% (better)7.5%
Return on equity26.4% (better)−28.9%
Return on invested capital29.7% (better)0.62%
Financial health
Debt / equity0.03 (better)0.97
Net debt / EBITDA−0.4113.01 (better)
Interest coverage–0.4×
Current ratio2.65 (better)2.60
Altman Z-score11.94 (better)1.60
Piotroski F-score6 (better)5
Dividends and buybacks
Dividend yield0.78% (better)0.64%
Payout ratio22.4%–
Years of dividend growth5 (better)0
Dividend growth, 5Y average9.0% (better)0.00%
Buyback yield4.2% (better)3.7%
Shareholder yield5.0% (better)4.3%
Ownership
Held by institutions71.1%113%
Held by insiders1.3%0.73%
Insider net buying, 12 months−$19.6M–
Superinvestors holding11
Short interest, % of float–9.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.